7774 Stock | Chart | Japan Tissue Engineering Co. Ltd Stock Price Today, Chart, performance

Short Term Long Term Short Term Comparison Long Term Comparison

7774
1d-3.73%
1w-10.06%
1m10.81%
1y36.94%
7774
1y36.94%
5y-29.88%
10y-43.19%
20y0.00%

Bitcoin
-0.82%
-9.09%
-6.40%
106.24%
Bitcoin
106.24%
1,146.32%
11,770.30%
0.00%

Ethereum
-0.90%
-11.75%
-14.49%
45.57%
Ethereum
45.57%
1,828.08%
0.00%
0.00%

Gold
0.26%
2.56%
11.41%
20.52%
Gold
20.52%
88.92%
85.82%
499.35%

Silver
0.47%
4.25%
15.38%
14.30%
Silver
14.30%
94.94%
48.08%
306.93%

Apple
-2.19%
1.78%
0.04%
5.09%
Apple
5.09%
260.11%
-66.73%
39,041.00%

Amazon
-1.68%
-1.44%
4.92%
78.52%
Amazon
78.52%
96.45%
-43.46%
7,943.96%

Microsoft
-1.96%
-2.97%
-0.67%
45.75%
Microsoft
45.75%
259.81%
923.86%
2,532.12%

S&P 500
-1.20%
-2.84%
-1.08%
22.34%
S&P 500
22.34%
74.12%
171.80%
346.13%

Dow & Jones
-0.65%
-2.95%
-2.53%
11.36%
Dow & Jones
11.36%
42.65%
129.74%
261.03%

ATH

ATH Price$3,995.00
ATH Date2013-05-07
% since ATH-82.55%
% to ATH473.17%

ATL

ATL Price$202.50
ATL Date2008-08-22
% from ATL244.20%
Last Low Price$453
Last Low Date2022-12-28
% From Last Low53.86%

IPO

IPO Price$96,000.00
% Current ROI USD-99.27%
ATH Price$3,995.00
% ROI ATH 197,283.95%

[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="7774"]

Key Data [addtoany]

Current price	$697
Sector	Healthcare
Industry	Biotechnology
Today's High/Low	$714/$696
Volume	33,300.00
Previous Close	$724
52 Week High/Low	$811/$472
Market Cap	29,401,640,960.00
P/E Ratio	0
Forward P/E 1 Yr.	$0.00
Earnings Per Share(EPS)	$0
Annualized Dividend	$0

$697

[addtoany]

Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company offers autologous cultured epidermis and cartilage to medical institutions for the purpose of medical treatment.
It also provides tissue-engineered medical products, which are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured, and then transplanted back to the same patient.
In addition, the company researches and develops human 3-dimensional cultured tissue models for use in the development of cosmetics and drugs for external use, as well as in research that employs skin and cornea tissues.
Further, it offers regenerative medical products contract development and manufacturing, and contract research services. Japan Tissue Engineering Co., Ltd. was founded in 1999 and is headquartered in Gamagori, As of March 2, 2021, Japan Tissue Engineering Co., Ltd. operates as a subsidiary of Teijin Limited.

Annual Data \| Millions of US $ except per share data	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31
Cash on hand	-	-	-	-	-	-
Receivables	-	$641.43	$543.04	$788.09	$454	$403
Inventory	-	$146.27	$135.19	$105.15	$123	$138
Pre-Paid Expenses	-	-	-	-	-	-
Other Current Assets	-	$195.30	$156.01	$21.33	$58	$149
Total Current Assets	-	$7,024.20	$7,139.67	$5,070.38	$4,501	$6,672
Property, Plant, And Equipment	$1,621	$1,651	$1,656	$1,725	$1,821	$1,697
Long-Term Investments	-	$4	$204	$1,706	$1,909	$409
Goodwill And Intangible Assets	-	-	-	-	-	-
Other Long-Term Assets	$1	$54	$1	$8	$17	$27
Total Long-Term Assets	-	$1,727.77	$1,883.40	$3,475.98	-	-
Total Assets	-	$8,751.97	$9,023.07	$8,546.37	$8,296	$8,853
Total Current Liabilities	-	$795.90	$733.85	$498.43	$490	$346
Long Term Debt	-	-	-	-	-	-
Other Non-Current Liabilities	$36	$35	$37	$36	$74	$92
Total Long Term Liabilities	-	$37.95	$37.79	$42.80	-	-
Total Liabilities	-	$833.85	$771.64	$541.23	$578	$456
Common Stock Net	$4,958	$4,958	$4,958	$4,949	$11,518	$11,517
Retained Earnings (Accumulated Deficit)	$-116	$170.88	$504.13	$276.24	$-13,149	$-12,467
Comprehensive Income	-	-	-	-	-	-
Other Share Holders Equity	$1	$2	$1	$1	$1	-
Share Holder Equity	-	$7,918.12	$8,251.43	$8,005.14	$7,718	$8,397
Total Liabilities And Share Holders Equity	-	-	-	-	-	-

Annual Data | Millions of US $ except per share data

2020-03-31

2019-03-31

2018-03-31

2017-03-31

2016-03-31

2015-03-31

Cash on hand

Receivables

$641.43

$543.04

$788.09

$454

$403

Inventory

$146.27

$135.19

$105.15

$123

$138

Pre-Paid Expenses

Other Current Assets

$195.30

$156.01

$21.33

$58

$149

Total Current Assets

$7,024.20

$7,139.67

$5,070.38

$4,501

$6,672

Property, Plant, And Equipment

$1,621

$1,651

$1,656

$1,725

$1,821

$1,697

Long-Term Investments

$204

$1,706

$1,909

$409

Goodwill And Intangible Assets

Other Long-Term Assets

$54

$17

$27

Total Long-Term Assets

$1,727.77

$1,883.40

$3,475.98

Total Assets

$8,751.97

$9,023.07

$8,546.37

$8,296

$8,853

Total Current Liabilities

$795.90

$733.85

$498.43

$490

$346

Long Term Debt

Other Non-Current Liabilities

$36

$35

$37

$36

$74

$92

Total Long Term Liabilities

$37.95

$37.79

$42.80

Total Liabilities

$833.85

$771.64

$541.23

$578

$456

Common Stock Net

$4,958

$4,949

$11,518

$11,517

Retained Earnings (Accumulated Deficit)

$-116

$170.88

$504.13

$276.24

$-13,149

$-12,467

Comprehensive Income

Other Share Holders Equity

Share Holder Equity

$7,918.12

$8,251.43

$8,005.14

$7,718

$8,397

Total Liabilities And Share Holders Equity

Annual Data \| Millions of US $ except per share data	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31
Revenue	-	$2,357.92	$2,271.51	$2,135.15	$1,430	$1,321
Cost Of Goods Sold	-	$1,073.17	$918	$911.08	$852	$794
Gross Profit	-	-	-	-	-	-
Research And Development Expenses	-	$606.56	$199.91	$20.74	$140	$389
SG&A Expenses	-	$75.11	$50.91	$63.79	$1,051	$959
Other Operating Income Or Expenses	$54	$26	$41	$44	$64	$51
Operating Expenses	-	$2,707.66	$2,059.99	$1,822.75	$2,153	$2,234
Operating Income	-	$-349.74	$211.51	$312.40	$-723	$-913
Total Non-Operating Income/Expense	-	-	-	-	-	-
Pre-Tax Income	-	$-339.63	$213.33	$309.95	$-678	$-687
Income Taxes	$57	$-6	$-14	$33	$3	$3
Income After Taxes	$57	$-6	$-14	$33	$3	$3
Other Income	-	-	-	-	-	-
Income From Continuous Operations	-	$-333.25	$227.89	$276.24	$-681	$-690
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	-	$-333.25	$227.89	$276.24	$-681	$-690
EBITDA	-	-	-	-	-	-
EBIT	-	$-349.74	$211.51	$312.40	$-723	$-913
Basic Shares Outstanding	-	-	-	-	-	-
Shares Outstanding	-	-	-	-	-	-
Basic EPS	-	-	-	-	-	-
EPS - Earnings Per Share	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31
Net Income/Loss	-	$-333.25	$227.89	$276.24	$-681	$-690
Total Depreciation And Amortization - Cash Flow	-	$119.68	$116.20	$112.95	$136	$86
Change In Accounts Receivable	-	$-142	$242	$-379	$-50	$-108
Change In Inventories	-	$-11.09	$-30.04	$18.08	$14	$-30
Cash Flow From Operating Activities	$-84	$-396.11	$632.01	$54.95	$-346	$-756
Cash Flow From Investing Activities	$209	$27	$-429	$-22	$-2,959	$-1,425
Debt Issuance/Retirement Net - Total	-	-	-	-	-	$-549
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	$-3	$-5	$-7	$-8	$-7	$-7
Cash Flow From Financial Activities	-	$-5	$11	$3	$-5	$6,341
Net Cash Flow	-	$-374.21	$214.07	$35.87	$-3,312	$4,159
Common Stock Dividends Paid	-	-	-	-	-	-